Axsome Therapeutics, Inc. — Form D/A
Axsome Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2013-10-30. The offering totals $4.0M, of which $3.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-10-30
- Form: D/A
- Accession: 0001579428-13-000004
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $3.7M
- Remaining: $321K
- Investors: 41
- Date of first sale: 2013-06-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-199018
Issuer
- Name: Axsome Therapeutics, Inc.
- CIK: 0001579428
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 45 ROCKEFELLER PLAZA, 20th Floor, NEW YORK, NY, 10111
- Phone: 212-203-5072
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Herriot Tabuteau | Director | New York, NY |
| Herriot Tabuteau | Executive Officer | New York, NY |
| Herriot Tabuteau | Promoter | New York, NY |
Other filings by this issuer (5)
More